Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • zeam
    Member
    • Oct 2010
    • 43

    #1

    Is BQSR necessary for de novo mutation calling?

    Hi there,
    I have been using GATK to identify variants recently. I saw that BQSR is highly recommended. But I don’t whether it is still needed for de novo mutation calling. For example, I want to identify de novo mutations generated in the progenies by single seed descent methods in plants. For example, in the paper of “The rate and molecular spectrum of spontaneous mutations in Arabidopsis thaliana”, these spontaneous arising mutations may not included in the known sites of variants. Based on documentation posted in GATK websites, they assume that all reference mismatches we see are therefore errors and indicative of poor base quality. Under this assumption, these de novo mutations may be missed in the step of variant calling. So in this situation, what should I do? Or should I skip the BQSR step?
    Also what should I do when I reach to step- VQSR?
    Hope some GATK developers can help me on this.
    Thanks.

Latest Articles

Collapse

  • SEQadmin2
    16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
    by SEQadmin2




    NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
    Today, 06:46 AM
  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-28-2026, 09:57 AM
0 responses
22 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-28-2026, 09:51 AM
0 responses
14 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
67 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
47 views
0 reactions
Last Post SEQadmin2  
Working...